MIACALCIC 50 IU/ml Price

Overview

Welcome to Dwaey, specifically on MIACALCIC 50 IU/ml Injection page.
This medicine contains an important and useful components, as it consists of Calcitonin (salmon, synthetic).
MIACALCIC 50 IU/ml is available in the market in concentration 50 IU/ml and in the form of Injection.

NOVARTIS PHARMA AG is the producer of MIACALCIC 50 IU/ml and it is imported from SWITZERLAND, The most popular alternatives of MIACALCIC 50 IU/ml are listed downward .

Mode Of Action

It inhibits osteoclastic bone resorption and reduces bone turnover. It decreases tubular reabsorption and promotes renal excretion of Ca, Cl, Na, Mg, K and phosphate.

Indication

• Hypercalcaemia
• Paget's disease of bone
• Postmenopausal osteoporosis.

Precaution

Children <18 yr, renal impairment. Pregnancy, lactation. Serious hypersensitivity reactions, including fatal anaphylaxis, reported; consider skin testing prior to treatment. Hypocalcemia associated with tetany has been reported; ensure adequate intake of calcium and vitamin D Lactation: excretion in milk unknown/not recommended

Side Effects

• >10% Rhinitis (12%) 1-10% Arthralgia (4%)
• Back pain (5%)
• Expistaxis (4%)
• Injection site reactions (10%)
• Nausea (10%)
• Headache (3%)
• Flushing of face or hands (2-5%) <1% Abdominal pain
• Possible allergic reactions
• Appetite decreased
• Edema of feet
• Eye pain
• Feverish sensation
• Nausea
• Nocturia
• Possible local irritative effects in the respiratory tract
• Salty taste Frequency Not Defined Tremors Potentially Fatal: Anaphylactic shock.

Contra indication

Hypersensitivity.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks